Rua Life Sciences Plc
(LSE) RUA
Rua Life Sciences Plc Financials at a Glance
Market Cap
£13.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
£8.57M
Net Income (TTM)
-£144.33K
EPS (TTM)
£0.00
P/E Ratio
47.83
Dividend
£0.00
Beta (Volatility)
-0.06 (Low)
Dividend
£0.00
Beta (Volatility)
-0.06 (Low)
Price
£0.23
Volume
26,500
Open
£0.23
Price
£0.23
Volume
26,500
Open
£0.23
Previous Close
£0.22
Daily Range
£0.23 - £0.23
52-Week Range
£0.10 - £0.27
Estimated Earnings Date
Jan 25, 2027
Dividend
£0.00
Beta (Volatility)
-0.06 (Low)
Price
£0.23
Volume
26,500
Open
£0.23
Previous Close
£0.22
Daily Range
£0.23 - £0.23
52-Week Range
£0.10 - £0.27
Estimated Earnings Date
Jan 25, 2027
RUA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rua Life Sciences Plc
Industry
Healthcare Equipment and Supplies
Sector
Health CareCEO
Bill Brown
Website
www.aortech.comHeadquarters
Irvine, KA11 5AN, GB
RUA Financials
Key Financial Metrics (TTM)
Gross Margin
68.56%
Operating Margin
-18.54%
Net Income Margin
-3.26%
Return on Equity
-2.03%
Return on Capital
-10.41%
Return on Assets
-1.59%
Earnings Yield
2.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
£13.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
62.06M
Volume
26.50K
Avg. Volume
262.74K
Financials (TTM)
Gross Profit
£6.05M
Operating Income
-£1.82M
EBITDA
£17.67K
Operating Cash Flow
-£352.00K
Capital Expenditure
-£223.00K
Free Cash Flow
-£575.00K
Cash & ST Invst.
£3.25M
Total Debt
£1.35M
Rua Life Sciences Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
£2.59M
+85.3%
Gross Profit
£1.66M
+50.9%
Gross Margin
64.12%
N/A
Market Cap
£13.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
£341.33K
N/A
Employees
40
N/A
Net Income
-£630.00K
-46.5%
EBITDA
-£1.10M
-175.7%
Quarterly Fundamentals
Total Cash
£3.25M
-17.3%
Total Debt
£1.35M
+248.1%
Accounts Receivable
£1.25M
+135.0%
Inventory
£894.00K
+698.2%
Long Term Debt
£1.12M
+311.8%
Short Term Debt
£234.00K
+100.0%
Return on Assets
-1.59%
N/A
Return on Invested Capital
-10.39%
N/A
Free Cash Flow
-£300.00K
+34.5%
Operating Cash Flow
-£166.00K
+62.7%